Risk-based monitoring and E6(R3): is the CRA travel role really shrinking?

The rules that govern how trials are monitored are changing, and CRAs should understand the change because it points at the future of the job. The updated good clinical practice standard, ICH E6(R3), now rolling out across the industry, elevates risk-based and centralized monitoring from an option to a core expectation. Here is what it actually requires and whether it really means less travel.

What E6(R3) changes

The old standard treated centralized monitoring as an acceptable option alongside traditional on-site visits. The updated standard makes it an essential pillar. Three shifts matter for the person doing the work. First, it favors source data review, a smarter and more targeted look at the data, over exhaustive 100 percent source data verification, the line-by-line checking that defined the traditional CRA visit. Second, it replaces calendar-based visit schedules with risk-triggered ones: a site performing well on centralized indicators may receive fewer on-site visits, while a struggling site draws more. Third, it leans heavily on digital tools, dashboards and electronic data, to catch problems remotely and in near real time.

Crucially, E6(R3) does not eliminate the site visit. It reframes it as a targeted intervention, reserved for the things remote oversight cannot do well: checking informed consent records, delegation logs, and specific concerns a dashboard flags. The visit becomes precise rather than routine.

Does it actually reduce travel?

The honest answer is that it changes the mix more than it slashes the total. Centralized monitoring enables fewer and less frequent on-site visits, and regulators are encouraging sponsors to move resources from travel toward central review. But no clean industry statistic yet quantifies the travel reduction, and the site visit persists for the tasks that require presence. The realistic read is a gradual shift: less pure source-verification road work, more remote data review, not the disappearance of monitoring travel.

What it asks of CRAs

The standard demands upskilling, and that is the real career signal. Risk- based oversight requires comfort with analytics tools and dashboards, judgment about where risk actually sits, and the ability to work from data rather than from a checklist. The value moves from the CRA who can verify every field on site to the CRA who can read a monitoring dashboard, spot the site that is drifting, and target the visit that matters. Some CROs are already restructuring around this, pooling CRAs into centralized monitoring teams that cover many sites remotely.

For a CRA, that is both a threat and an opportunity. The threat is to the travel-heavy, verification-focused model that defined the role for decades. The opportunity is that the analytical, judgment-heavy version of monitoring the standard rewards is harder to automate or offshore than line-by-line checking, and it sits closer to the senior half of the job.

What the standard cannot tell you

E6(R3) tells you how monitoring is supposed to work. It cannot tell you whether your employer actually cut your travel or just added dashboard work on top of it, whether the upskilling came with a raise, or how the centralized-monitoring shift is really landing on CRAs day to day. Those are the lived effects, and they only exist with the people monitoring trials right now. If the shift to risk-based monitoring has changed your job, add your datapoint, and show what the standard looks like in practice.